You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTNM Exercise Disclosure
Lorrain Daniel S. · SEC Form 4 · Filed Jul 10, 2026
Exercise
Calculated transaction value
$1.03K
Lorrain Daniel S. Chief Scientific Officer
CTNM
Transaction date
Jul 8, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed 2 days later
CTNM daily price context
Close on/before transaction
$15.65
Jul 8, 2026
First close after public filing
$14.62
Jul 13, 2026
30-day return after filing
-0.89%
Through Aug 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 1,015 shares @ $1.01
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001628280-26-047909
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
$17.69K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Contineum Therapeutics, Inc. CTNM | Exercise | Jul 9, 2026 | $25.25 |
| Contineum Therapeutics, Inc. CTNM | Sale | Jul 9, 2026 | $400 |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jul 9, 2026 | $0 |
| Contineum Therapeutics, Inc. CTNM Current | Exercise | Jul 8, 2026 | $1.03K |
| Contineum Therapeutics, Inc. CTNM | Sale | Jul 8, 2026 | $16.24K |
| Contineum Therapeutics, Inc. CTNM | Exercise | Jul 8, 2026 | $0 |